Lucinactant US-DRUG Not yet graded
Earliest US approval2012
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008961
Compound index — L
887 substances begin with L. 2 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 87 of them, Lucinactant – Lytta Vesicatoria.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Lucuma obovata EU-NOVEL Not yet graded
Not novel in food
also: Lucuma obovata Kunth; Pouteria lucuma (Ruiz & Pav.) Kuntze
Parts in scopeFruits
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008962
Ludwigia prostrata CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008963
Lufenuron US-DRUG Not yet graded
US: bulk ingredient
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008964
Luffa Acutangula Fruit US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008965
Luffa aegyptiaca CA-NHP Not yet graded
CA licensed ingredient
Market presence42 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008966
Luffa amara CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008967
Luffa cylindrica CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008968
Luffa operculata CA-NHP Not yet graded
CA licensed ingredient
Market presence40 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008969
Luffa Operculata Fruit US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Animal Fur [CS]
Market presence38 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008970
Luffa Operculata Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAscorbic Acid [CS]; Vitamin C [EPC]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008971
Luliconazole US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAzole Antifungal [EPC]; Azoles [CS]; Cytochrome P450 2C19 Inhibitors [MoA]
Earliest US approval2013
Market presence4 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008972
Lumacaftor EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedChloride Channel Activation Potentiators [MoA]; Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]
Earliest US approval2015
Market presence10 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-008973
Lumateperone US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAtypical Antipsychotic [EPC]
Earliest US approval2019
Market presence10 US product listings · 6 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008975
Lumbricus rubellus CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008976
Lumbrokinase CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008977
Lumefantrine US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAntimalarial [EPC]
Earliest US approval2009
Market presence4 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008978
Lunsotogene Parvec US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008979
Lupinus albus EU-NOVEL Not yet graded
Not novel in supplements
Parts in scopeSeeds
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008980
Lupinus angustifolius EU-NOVEL Not yet graded
Not novel in food
Parts in scopeSeeds
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008981
Lupinus Elegans Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008982
Lupinus luteus EU-NOVEL Not yet graded
Not novel in food
Parts in scopeSeeds
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-008983
Lupuli flos EU-HERB Not yet graded
Herbal monograph: C: ongoing call for scientific data
also: Hop strobile; Humulus lupulusL.
Class as recordedherbal: Sleep disorders and temporary insomnia;Mental stress and moo
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-008984
Lupulinum CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008985
Lurasidone EU-MEDUS-DRUG Not yet graded
Lurbinectedin EU-MEDUS-DRUG Not yet graded
Luspatercept EU-MEDUS-DRUG Not yet graded
Luspatercept-Aamt US-DRUG Not yet graded
Earliest US approval2019
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008989
Lutein CA-NHPEU-CLAIMEU-NOVELUS-DRUG Not yet graded
Not novel in foodEU claims 0 authorised / 8 refusedCA licensed ingredientUS: unapproved drug other
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Calculi Dissolution Agent [EPC]
Market presence1 US product listings · 1,099 Canadian licensed products
Parts in scopeSubstance
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps support skin health /helps promote healthy skin /helps maintain healthy skin /helps to maintain your skin's healthy look and feel /is deposited naturally in the skin /is a natural compound contained in the dermis and epidermis /is a natural compound contained in the deepest layers of the skin /nutrition for skin /helps maintain skin moisture /helps maintain skin hydration /improves skin moisture /helps improve…” | Non-authorised | Art.13(1) | EFSA opinion |
| “Lutein promotes healthy eye function. Lutein and zeaxanthin help protect the retina against oxidation / from oxidative stress. Lutein is a constituent of the macular pigment. Lutein and zeaxanthin are deposited naturally in the macula and lens. Lutein and zeaxanthin are highly and selectively accumulated in the macula and lens / in the retina Lutein contributes to eye health. Lutein helps maintain the normal…” | Non-authorised | Art.13(1) | EFSA opinion |
| “natural antioxidant, protect organism from oxidative damage, natural way to avoid risks caused by oxidation and peroxidation process” | Non-authorised | Art.13(1) | EFSA opinion |
| “Lutein is a natural antioxidant which protects the skin from the harmful effects of free radicals 2. Lutein helps protect the retina and lens from free radicals which result from UV-radiation 3. Lutein is a natural antioxidant for eyes 4.Lutein protects the eye from the harmful effects of free radicals 5. Lutein helps protect the macular pigment from the harmful UV-radiation and oxygen-containing free radicals” | Non-authorised | Art.13(1) | EFSA opinion |
| “Lutein is a natural antioxidant which protects the skin from the harmful effects of free radicals 2. Lutein helps protect the retina and lens from free radicals which result from UV-radiation 3. Lutein is a natural antioxidant for eyes 4.Lutein protects the eye from the harmful effects of free radicals 5. Lutein helps protect the macular pigment from the harmful UV-radiation and oxygen-containing free radicals” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps support eye health Helps maintain healthy eyes Nutrition for eyes Promotes healthy eye function/helps maintain macular and retinal health Is one (of the) constituent(s) of the retina and the lens Is deposited naturally in the eye Is a constituent of the macular pigment Is highly and selectively accumulated in the retina Is highly and selectively accumulated in the macula lutea Contributes to macular pigment…” | Non-authorised | Art.13(1) | EFSA opinion |
| “Lutein helps maintain a healthy vision Lutein–for maintenance of a healthy sight Lutein–for maintenance of healthy eyes” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps maintaining healthy eye function. Oral supplementation of Lutein and Zeaxanthin helps increasing macular pigment levels in plasma and retina. Oral supplementation with lutein results in increase in concentration of lutein in serum and macular pigment Helps enhance visual acuity in persons with compromised visual function Helps improve visual performance in persons with compromised visual function” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-008991
Lutein esters CA-NHP Not yet graded
CA licensed ingredient
Market presence159 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-008992
Lutein/zeaxanthin EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Due to the antioxidant properties lutein/ zeaxanthin/ contributes to the hindrance of harmful oxidative processes in the body, in this way to the maintenance of our health/ to the defence of the tissues.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Eye protection factor(s)” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-008993
Lutetium EU-MEDUS-DRUG Not yet graded
lutetium (177Lu) oxodotreotide EU-MED Not yet graded
EU medicine: Authorised
Class as recordedV10XX04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-008999
lutetium (177Lu) vipivotide tetraxetan EU-MED Not yet graded
EU medicine: Authorised
Class as recordedV10XX
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-009001
Lutetium Chloride LU-177 US-DRUG Not yet graded
US: bulk ingredient for human prescription compounding
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008995
Lutetium LU 177 Dotatate US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008996
Lutetium LU-177 US-DRUG Not yet graded
US: drug for further processing
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008997
Lutetium LU-177 Vipivotide Tetraxetan US-DRUG Not yet graded
US: nda
Class as recordedRadioligand Activity [MoA]; Radioligand Therapeutic Agent [EPC]
Earliest US approval2022
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-008998
Lutetium Oxodotreotide LU-177 US-DRUG Not yet graded
US: nda
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009000
Lutrelin US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Increased Uterine Smooth Muscle Contraction or Tone [PE]; Oxytocic [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009002
lutropin alfa EU-MED Not yet graded
EU medicine: Authorised
Class as recordedG03GA07; G03GA30
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-009003
Luzerne CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009004
Lycium barbarum CA-NHPEU-CLAIMEU-NOVEL Not yet graded
Not novel in foodEU claims 0 authorised / 1 refusedCA licensed ingredient
also: Lycium barbarum Mill.
Market presence1,461 Canadian licensed products
Parts in scopeFruits (berries)
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Contains antioxidant/s; Is a source of antioxdiant/s. With antioxidant/s. Contributes to the cell protection against free radicals Can protect your cells and tissues from oxidation Can contribute to the total antioxidant capacity of the body” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-009005
Lycium chinense CA-NHP Not yet graded
CA licensed ingredient
Market presence150 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009006
Lycium Chinense Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009007
Lycium ruthenicum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009008
Lycopene CA-NHPEU-CLAIMEU-NOVEL Not yet graded
Not novel in supplementsEU claims 0 authorised / 7 refusedCA licensed ingredient
Market presence819 Canadian licensed products
Parts in scopeSubstance/extract/preparation; Synthetic lycopene; Lycopene from Blakeslea trispora
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Contributes to the maintenance of healthy skin when exposed to sun light. (Avoid sunburns by using an effective sun screen. Lycopene is not a replacement for sun screens).” | Non-authorised | Art.13(1) | EFSA opinion |
| “Contributes to the normal functioning of the prostate/helps to maintain a healthy prostate/helps to keep your prostate in shape/helps to reduce oxidative damage of prostate cells and tissue/helps to maintain intact DNA in prostate tissue” | Non-authorised | Art.13(1) | EFSA opinion |
| “Good for the eye health of older people.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps to maintain a healthy heart/contributes to maintain a healthy cardiovascular system/contributes to protect the arteries from narrowing and hardening/contributes to keep the arteries healthy/helps to maintain a normal blood flow.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Lycopenes contained in this product ensure antioxidant action. Ensure protective effect on the organism. Contribute to the protection of the cellular membranes from oxidation.” | Non-authorised | Art.13(1) | EFSA opinion |
| “lycopene is an antioxidant and helps to protect the body's cells/helps to maintain intact body cells. Lycopene or a diet rich in lycopene helps to maintain intact cell DNA/contributes to healthy ageing by maintaining intact cell DNA/” | Non-authorised | Art.13(1) | EFSA opinion |
| “Lycopene from tomato extract has an antioxidant effect. Lycopenes contained in this product have an antioxidant action/ ensure a protective effect on the organism/contribute to the protection of the cellular membranes from oxidation.” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-009009
Lycopene-whey complex EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Lycopene-whey complex prevents oxidative damage of plasma lipoproteins, which reduces the build up of arterial plaques and reduces the risk of heart disease, stroke and other clinical complications of atherosclerosis” | Non-authorised | Art.14(1)(a) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009010
Lycopenes from tomato juice EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “(Lycopenes from) tomato juice: - plays an important antioxidative function - protect cells against oxidative damages - strengthen the immune system - strengthen the body's defences” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009011
Lycopenes from tomato juices EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Lycopenes contained in this product ensure antioxidant action/lycopenes contained in this product ensure protective effect on the organism; antioxidant/s.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009012
Lycopenes from tomato pulp and sauces EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Tomato is as almost unique as a source of a specific carotene named: Lycopene; Therefore use it always is any conditions for its nutritional qualities” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-009013
Lycoperdon Utriforme Fruiting Body US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence45 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009014
Lycopersicon esculentum CA-NHP Not yet graded
CA licensed ingredient
Market presence64 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009015
Lycopersicon lycopersicum CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009016
Lycopersicum esculentum CA-NHP Not yet graded
CA licensed ingredient
Market presence38 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009017
Lycopodium CA-NHP Not yet graded
CA licensed ingredient
Market presence36 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009018
Lycopodium clavatum CA-NHPEU-CLAIM Not yet graded
EU claims 0 authorised / 1 refusedCA licensed ingredient
Market presence333 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Contributes to normal urinary elimination functions” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-009019
Lycopodium Clavatum Spore US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Acidifying Activity [MoA]; Actively Acquired Immunity [PE]
Market presence734 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009020
Lycopodium Clavatum Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009021
Lycopodium complanatum CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009022
Lycopodium japonicum CA-NHP Not yet graded
CA licensed ingredient
Market presence51 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009023
Lycopus americanus CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009024
Lycopus lucidus CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009025
Lycopus lucidus var. hirtus CA-NHP Not yet graded
CA licensed ingredient
Market presence69 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009026
Lycopus Virginicus CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence35 US product listings · 22 Canadian licensed products
Etalyn identifierETA-C-009027
Lycopus Virginicus Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]
Market presence19 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009028
Lycosa Tarantula US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Anticholinergic [EPC]
Market presence45 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009029
Lygodium japonicum CA-NHP Not yet graded
CA licensed ingredient
Market presence37 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009030
Lygodium Japonicum Spore US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009031
Lypressin US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009032
Lysergic acid US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: hallucinogen / synthetic cannabinoid
DEA other namesLSD precursor
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-009033
Lysergic acid amide US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: hallucinogen / synthetic cannabinoid
DEA other namesLSD precursor
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-009034
Lysergic acid diethylamide US-CSA Not yet graded
CSA Schedule I
Class as recordedDEA: hallucinogen / synthetic cannabinoid
DEA other namesLSD; lysergide
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-009035
Lysimachia Arvensis Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009036
Lysimachia christinae CA-NHP Not yet graded
CA licensed ingredient
Market presence63 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009037
Lysimachia Christinae Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009038
Lysine CA-NHPEU-CLAIMEU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedEU claims 0 authorised / 8 refusedCA licensed ingredientUS: anda
Class as recordedAcidifying Activity [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]
Market presence84 US product listings · 1 EU medicines · 1,663 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Lysine can contribute to the development and maintenance of the normal structure of bones.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Essential amino acid, needed for the synthesis of proteins necessary for maintenance of the body/ body tissues (collagen, teeth, bones and muscles)/ body function. Increases absorption, action and fixation of calcium, essential for optimal muscle, bone and teeth.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Essential amino acid, needed for the synthesis of proteins necessary for maintenance of the body/ body tissues (collagen, teeth, bones and muscles)/ body function. Increases absorption, action and fixation of calcium, essential for optimal muscle, bone and teeth.” | Non-authorised | Art.13(1) | EFSA opinion |
| “It improves liver function. To stimulates the appetite in a natural way” | Non-authorised | Art.13(1) | EFSA opinion |
| “Lysine is an essential amino acid that is necessary for maintenance of the body/body tissues/body function. Addition of lysine enhances of cereal protein quality” | Non-authorised | Art.13(1) | EFSA opinion |
| “Lysine is an essential amino acid that is necessary for maintenance of the body/body tissues/body function. Addition of lysine enhances of cereal protein quality” | Non-authorised | Art.13(1) | EFSA opinion |
| “Lysine supports the cardiovascular system functions.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Lysine supports the immune systems functions” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-009039
Lysine HCL US-DRUG Not yet graded
US: drug for further processing
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009040
Lysionotus pauciflorus CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009043
Lyssin CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009045
Lyssin/Hydrophobinum CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009046
Lythrum salicaria CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-009047
Lythrum Salicaria Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-009048
Lytta Vesicatoria CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence156 US product listings · 8 Canadian licensed products
Etalyn identifierETA-C-009049